Quick Overview: At the International Workshop on Non-Hodgkin Lymphoma ( For the past fifteen years, Lymphoma & Myeloma has been the premier forum on the latest advances in lymphoma, myeloma, and ... John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, ...

Iwnhl 2015 Roundtable Immune Checkpoint - Detailed Overview & Context

At the International Workshop on Non-Hodgkin Lymphoma ( For the past fifteen years, Lymphoma & Myeloma has been the premier forum on the latest advances in lymphoma, myeloma, and ... John Gribben, MD, DSc, FRCPath, FRCP FMedSci, of Barts and The London School of Medicine and Dentistry, London, UK, ... Stephen Ansell, MD, PhD, from the Mayo Clinic, Rochester, MN, USA, briefly describes the effectiveness and recent approval of ... The continued evolution and refinement of strategies for disease diagnosis, risk assessment, therapeutic intervention and disease ... Yale Cancer Center Grand Rounds May 21, 2019 Roy Decker, MD, PhD, Vice Chair for Clinical Research and Professor of ...

Yevgeniy R. Semenov, MD, Massachusetts General Hospital, Boston, MA, discusses a study of 14000 patients who received ...

Photo Gallery

iwNHL 2015 roundtable: Immune checkpoint blockade for non-Hodgkin lymphoma
iwNHL 2015 roundtable: Future directions for the management of non-Hodgkin lymphoma
iwNHL 2015 roundtable: Biology of diffuse large B-cell lymphoma
iwNHL 2015 roundtable: Molecular biology of T-cell lymphoma
Immune Checkpoint Inhibitors in Hodgkin and non-Hodgkin Lymphoma
iwNHL 2015 roundtable: The changing treatment landscape for non-Hodgkin lymphoma
iwNHL 2015 roundtable: Day 1 highlights
iwNHL 2015 roundtable: Day 2 highlights – CAR T-cell therapy for non-Hodgkin lymphoma
iwNHL 2015 roundtable: Using B-cell biology to inform therapy
iwNHL 2015 roundtable: Day 2 highlights – PI3K inhibitors
Determining effective combinations of immune checkpoint inhibitors for lymphoma
iwNHL 2015 roundtable: Novel therapeutic combinations for relapsed/refractory T-cell lymphoma
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored